Mumbai: The All India Food and Drug License Holder (AIFDLH) Association have decided not to supply any medicine to the civic-run hospitals until the administration does not take any action against the medical superintendents who were pulled over shortage of medicines. Meanwhile, the Brihanmumbai Municipal Corporation (BMC) has blacklisted one more medicine supplier over delay in supplying drug tablets and capsules. This comes after AIFDLH challenged the decision of the civic administration and also alleged medical superintendents of 17 peripheral hospitals, 33 maternity homes and 112 dispensaries who were pulled up over shortage of medicine at the facilities, have faced no action apart from a single show cause notice.
Abhay Pandey, president, AIFDLH said they had meeting with the civic commissioner in regarding asking them cancel the wrong blacklisting of medicines supplier and take action against the medical superintendents and heads of maternal hospitals and dispensaries for being equally responsible for the shortage of supply. “We want all officials who are responsible for delay payments to be punished. Because delayed payment is the main reason for delayed supplies. Medico blacklisting should be cancelled immediately,” he said. Sunil Dhamne, deputy municipal commissioner (health), said they have already issued the notices to all medical superintendents and heads of health facilities, asking them why they did not take appropriate measures at the time of delay of supply.
BMC’s show cause notice
BMC has issued a show cause notices to eleven medicine suppliers for delay in medicine supply to all the medical facilities, including major and peripheral hospitals, maternity homes and dispensaries. Of which two have been blacklisted for a period of five years and nine others are barred from taking part in the next years tendering process.
“You have delayed supply of tablets and capsules allotted to you for 2017-19. Hence (you caused) shortage of medicine in Municipal hospitals, maternity homes and dispensaries. Ultimately poor patients suffered,” said the notice issued to the medicine supplier on June 25.
